Some serum tumor markers, such as neuron-specific enolase (NSE), carcinoembryonic antigen (CEA), alkaline phosphatase (ALP), and hemoglobin (Hb), are considered to be an important diagnostic and prognostic indicator for patients with renal cell carcinoma [14–17]. The gene discussed is ENO2; the disease is renal cell carcinoma.